Scilex Holding Company (SCLX) - News Archive

Scilex Holding Company (Nasdaq: SCLX), known for its focus on non-opioid pain management solutions, has been actively pursuing strategic partnerships and initiatives that signal its commitment to enhancing operational c...

Scilex Holding Company Executes 1-for-35 Reverse Stock Split Amid Recent Legal DevelopmentsPALO ALTO, Calif. April 11, 2025 Scilex Holding Company (Nasdaq: SCLX), an innovative revenue-generating firm focusing on the ac...

Scilex Holding Company: Navigating Lockup Extensions and Compliance Triumphs Amid Strategic ExpansionPALO ALTO, Calif. Jan. 31, 2025 In a pivotal moment for Scilex Holding Company (Nasdaq: SCLX), the U.S. Bankruptcy Cou...

In a recent press release, Scilex Holding Company (Nasdaq: SCLX) announced that it has successfully regained compliance with The Nasdaq Stock Market LLC s Listing Rule 5250(c)(1). This development comes in the wake of t...

Scilex Holding Company Faces Financial Strain Amid New Study on ZTlido vs. Lidocaine PatchScilex Holding Company Announces Pain Medicine Study and Financial Challenges Palo Alto, CA – January 13, 2025 – Scilex Holding C...

In a strategic move designed to bolster investor confidence, Scilex Holding Company has announced a new record date for the distribution of its preferred stock dividend January 28, 2025. This announcement, dated Decembe...

: In a groundbreaking development within the global pharmaceutical landscape, Scilex Bio, a significant part of the Scilex Holding Company, has entered into a binding agreement with NeuroBiogen for a global license of t...

Innovative Pathways in Obesity Management: Scilex Bio Leads the Charge PALO ALTO, Calif. Dec. 11, 2024 In a groundbreaking step towards combatting obesity, Scilex Bio, a joint venture led by Scilex Holding Company (Nasd...

PALO ALTO, Calif. Dec. 12, 2024 - Scilex Holding Company (Nasdaq: SCLX), a company focused on delivering innovative treatments for neurodegenerative and cardiometabolic diseases, as well as non-opioid pain management so...

In a notable development for stakeholders and analysts monitoring the non-opioid pain management industry, Scilex Holding Company (Nasdaq: SCLX) recently disclosed a notice from the Nasdaq Stock Market LLC regarding non...

PALO ALTO, Calif. November 6, 2024 - In a move poised to significantly alter the landscape of pain management and the financial trajectories of involved entities, Semnur Pharmaceuticals, a wholly owned subsidiary of Sci...

Scilex Holding Company Provides Key Updates for Shareholders: Implications of Extended Lockup and Dividend Share DemandIn a recent announcement, Scilex Holding Company (Nasdaq: SCLX), a Californian innovative firm dedic...

In a significant announcement for its stakeholders, Scilex Holding Company (Nasdaq: SCLX) has declared it will set a record date of November 7, 2024, for a dividend of preferred stock that can be exchanged for up to 10%...

Optimizing Pharmaceutical Success: Scilex Holding Company Explores Strategic Opportunities for Subsidiary Growth In a bold move, Scilex Holding Company (Nasdaq: SCLX), a vanguard in the pharmaceutical industry, has anno...

Scilex Holding Company: Pioneering a New Era in Non-Opioid Pain ManagementPALO ALTO, Calif. Oct. 16, 2024 - Scilex Holding Company (Nasdaq: SCLX), an innovative revenue-generating entity specializing in non-opioid pain...

Scilex Holding Company Announces Preliminary Third Quarter 2024 Financial Results Showcasing Robust Growth in Non-Opioid Pain Management Sector PALO ALTO, Calif. Oct. 08, 2024 - Scilex Holding Company (Nasdaq: SCLX), an...

In the ever-evolving landscape of biotechnology and pharmaceuticals, companies frequently encounter significant challenges that test their resilience and adaptability. Among these firms, Scilex Holding Company (Nasdaq:...

In the volatile landscape of biotechnology and pharmaceutical companies, few firms have navigated such choppy waters as Scilex Holding Company (Nasdaq: SCLX). This Palo Alto-based enterprise specializes in the developme...

Scilex Holding Company (Nasdaq: SCLX), an emerging player in the non-opioid pain management sector, has faced a tumultuous few months marked by legal challenges and market dynamics. Based in Palo Alto, California, the c...

PALO ALTO, Calif. Sept. 18, 2024 – Scilex Holding Company (Nasdaq: SCLX), an innovative revenue-generating organization dedicated to acquiring, developing, and commercializing non-opioid pain management products, recent...